shutterstock_1226709739_denphotos

DenPhotos / Shutterstock.com

14 September 2023Big PharmaMarisa Woutersen

US Court of Appeals sides with Apple in Masimo dispute

Court upholds USPTO and the PTAB decisions over blood-oxygen sensor in smartwatches | Ruling finds Masimo patents to be unpatentable and obvious | Only one claim relating to inconsistency to be reversed.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

Apple suffers another bruising in smartwatch tech clash

31 January 2023 Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.

Could Apple face an ITC import ban of its watches?

17 January 2023 With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.

More on this story

article

Apple suffers another bruising in smartwatch tech clash

31 January 2023 Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.

Could Apple face an ITC import ban of its watches?

17 January 2023 With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.

More on this story

article

Apple suffers another bruising in smartwatch tech clash

31 January 2023 Tech giant faces second setback in a month in dispute with Masimo | Patent Trial and Appeals Board denies its request for IPR.

Could Apple face an ITC import ban of its watches?

17 January 2023 With wearable health monitoring technology booming, Apple is facing several challenges to its smartwatch patents from medtech firms, and ITC investigations threatening import bans in the US. Sarah Speight reports.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB